Pediatric Dialysis Population With Lupus Nephritis Fare Worse Than Those With Nonlupus Glomerular Disease
Among children on dialysis, those with lupus nephritis were more likely to be hospitalized.
Systemic Lupus Erythematosus
Case Report: Chilblain Lupus-Like Cutaneous Reaction in Patient Receiving ICI Treatment for Oropharyngeal Cancer
In a letter to the editor, authors reported the case of chilblain lupus-like cutaneous reaction that fulfilled the criteria for systemic lupus erythematosus in a patient who received treatment with immune checkpoint inhibitors for oropharyngeal cancer.
Rituximab for Refractory Lupus Nephritis and Flare: Pediatric Rheumatologists vs Nephrologists
Using a web-based survey, study authors assessed the current practices of pediatric nephrologists and rheumatologists in North America with regard to the treatment of refractory proliferative lupus nephritis.
Plasma Sphingolipids as Biomarkers for the Early Diagnosis of Atherosclerosis in Systemic Lupus Erythematosus
Researchers assessed the role of plasma sphingolipids in predicting atherosclerosis severity in African American patients with systemic lupus erythematosus.
Increasing Lupus Clinical Trial Participation Among Black Women: Addressing Racism Through Communication and Community Engagement
Using Critical Race Theory, lead study author Rodlescia S. Sneed, PhD, MPH, and team assess the impact of racism on the representation of Black women with systemic lupus erythematosus in clinical trials, and highlight the need for interventions in this area.
The Past, Present, and Future of Lupus Treatments
Mary Crow, MD, and Christele Felix, a patient with lupus, each provide their perspectives on the recent FDA approval of anifrolumab for SLE treatment.
Poor Patient-Provider Communication and Low Patient Self-Efficacy Linked to SLE-Related Damage in African American Patients
Using a cross-sectional survey, researchers assessed the association of racial differences in patient-provider communication and patient self-efficacy with SLE-related damage.
COVID-19 Vaccines Appear to Be Well-Tolerated Among Patients With Systemic Lupus Erythematosus
The primary objective of the VACOLUP study was to assess the tolerance of COVID-19 vaccines, including risk for incident flares, in patients with systemic lupus erythematosus.
Identifying Principles of Diagnosis, Treatment of Lupus Nephritis in Childhood-Onset Systemic Lupus Erythematosus
The aim of the review was to identify and validate principles related to the diagnosis, treatment, and surveillance of lupus nephritis in childhood.
FDA Approves Anifrolumab-Fnia for Systemic Lupus Erythematosus
The FDA has approved Saphnelo (anifrolumab-fnia) for the treatment of adults with moderate to severe SLE who are receiving standard therapy.
- Loading...
Loading...
Next post in Systemic Lupus Erythematosus
Loading... 
Loading...